Sonic Healthcare Limited (SKHHY)
Sonic Healthcare Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $15.69, down 0.95% on the session, giving a market capitalisation of $7.75B. On trailing twelve-month figures it carries a trailing P/E of 20.09, a net margin of 5.2%. Its beta of 0.59 implies it has historically moved less than the broad market.
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.
Sonic Healthcare Limited is most often compared with the following Healthcare names: